Table 1 Serum phosphorus (P) category and mean serum P at baseline and after treatment (efficacy assessment phase; EAP) by iPTH achievement category during EAP
iPTH ≤300 pg/mL at EAP (N = 300) | iPTH > 300 pg/mL at EAP (N = 239) | |
|---|---|---|
Serum P category, no of patients (%) | ||
≤4.5 mg/dL at baseline | 88 (29) | 58 (24) |
≤4.5 mg/dL at EAP | 130 (43)* | 50 (21) |
≤5.5 mg/dL at baseline | 172 (57) | 125 (52) |
≤5.5 mg/dL at EAP | 209 (70)* | 111 (46) |
Serum P mean (SE) absolute values (mg/dL) | ||
Baseline | 5.5 (0.10) | 5.5 (0.10) |
EAP | 4.9 (0.09) | 5.6 (0.10) |
Change from baseline to EAP | −0.6 (0.08) | 0.1 (0.09) |
p-value** | <0.001 | 0.19 |